CAHP Statement: CAHP Releases Research Review On Northwestern University Finding that Medicaid Managed Care Lowers Drug Costs
The California Association of Health Plans today has released a research review of a recent non-partisan nationwide study conducted by a team of Northwestern University professors which found that allowing managed care organizations (MCO’s) to administer the majority of Medicaid drug benefits, as we currently do in California, significantly reduces state spending on prescription drugs.
CAHP Statement: CAHP Hires New Director of Regulatory Affairs and State Programs Analyst
The California Association of Health Plans (CAHP) today announced that Christina Wu is the association’s new Director of Regulatory Affairs and Ellesse Flores has joined the staff as State Programs Analyst.
CAHP Statement: Bill Designed to Lower Prescription Drug Prices by Cracking Down on Pharma’s Pay-for-Delay Schemes Passes Assembly Health Committee
AB 824, a bill that would curb increasing drug prices in Californiaby allowing more generic drugs to enter thehealth caremarketplace, cleared the Assembly Health Committee this afternoon. The measure, introduced by Assembly Health Committee Chairman Jim Wood (D-Santa Rosa)inpartnership with Attorney General Xavier Becerra, would prohibit “pay-for-delay” agreements where a pharmaceutical company transfers anything of value to delay a competitor’s research, marketing, or sale of a competing version of its drug.
CAHP Statement: Assembly Health Committee Passes Bill to Stop Third Party Payer Scheme from Driving Up Health Care Costs for All
Legislation designed toincreaseconsumer protection by reining-in a profiteering scheme operated by the dialysis and drug rehabilitation industries passed the Assembly Health Committee on a bipartisan vote.
Infographic: How Prescription Drug Costs Impact California Health Plan Premiums
In 2017, California enacted into law SB 17, groundbreaking legislation that is helping to shine a light on pharmaceutical companies’ efforts to spike prescription drug prices.
Infographic: How SB17 Works and Key Dates for 2019
SB 17 will help bring pharmaceutical companies’ pricing tactics out of the dark and address the growing affordability crisis by requiring drug companies to give health plans and others notice of major price increases for the most expensive drugs. While some key details of the law have been implemented, there is still much more activity to come in 2019.
CAHP Statement: New RunawayRx Infographics Explain California’s Drug Price Transparency Law and How It’s Working to Reveal How Rx Costs Impact Health Plan Premiums
RunawayRx today released two new infographics. One highlightskey implementation dates for California’s landmark prescription drug transparency law, SB 17, and the other revealsnew details about how prescription drug costs are impacting California health plan premiums.
Infographic: Understanding Health Plans’ Role in Pharmacy Benefit Delivery
Prescription drug benefits are an integral part of Medi-Cal managed care.
CAHP Statement: CAHP Issues Response to Newsom’s State-of-the-State Address
California Association of Health Plans President and CEO Charles Bacchi issued a statement today in response to Governor Gavin Newsom’s first state-of-the-state address.
CAHP Fact Sheet – Individual Shared Responsibility Requirement
Expanded Premium Assistance and a State-Based Individual Shared Responsibility Requirement Will Make Health Care More Affordable.
CAHP Fact Sheet: 5 Ways Health Plans are Supporting California's Hospitals